Health and Life Sciences
The Health and life sciences industry, more
than any other major industry, continues to be characterized by
rapid and unpredictable change. And with global demand not expected
to decline any time soon, extensive efforts in established markets
around the globe are well underway to mitigate the ever-rising
costs of providing quality health care.
Health and life sciences companies face a
number of challenges in developing and commercializing products and
delivering services domestically, as well as abroad. Factors such
as looming patent expirations, continued pricing pressure,
reimbursement restrictions, mounting regulatory requirements and
limited access to capital in the midst of the current economic
cycle pose unique obstacles to growth for every player in the
industry.
The interplay among dramatic scientific and medical advances, US
and European healthcare reform, regulatory uncertainty affecting
the introduction of new medical treatments, new limitations on
intellectual property protection and the rocky financial markets,
have created unprecedented burdens on executives seeking to improve
the human condition.
Our lawyers have extensive experience coping with all aspects of
the challenges facing health care and life sciences executives.
With the pace at which businesses and technology move and change to
meet the rigors of a competitive marketplace, our experience in the
particular substantive areas of law is not enough. We also assemble
all of the necessary pieces of the puzzle to meet the needs of our
clients, whether proactively or reactively.
Areas of Focus:
- Academic Medical
Centers
- Animal Health
- Biotechnology
- Durable Medical Equipment and Other
Suppliers
- Group Purchasing
Organizations
- Health Plans
- Health Professional Societies and
Associations
- Hospitals and Health
Systems
- Long-Term Health Care
Facilities
- Medical Devices
- Pharmaceuticals
- Physicians and Physician
Groups
- Plant Biology and Crop Science
- Retail Pharmacies